S&P also affirmed its “AA-” long-term and underlying rating on UCMC’s series 2009A, 2009B, 2009C, 2009D, 2009E, 2011C and 2012A bonds.
“The ratings reflect our opinion of UCMC’s robust operations, leadership team that has continued to meet or exceed its long-range plan and stable inpatient utilization,” said S&P analyst Brian Williamson.
The outlook is stable, reflecting S&P’s anticipation that UCMC will be able to maintain its strong financial profile and enterprise profile.
More articles on healthcare finance:
What this year’s Nobel Memorial Prize in Economics means for ACOs, physician compensation
The 3 states where medical debt is the biggest source of debt
New legal challenge in Indiana could provide avenue for uninsured to question healthcare prices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
